Media & Press
The democratization of health data and emerging solutions such as personal biobanking are paving a new age in healthcare. 2021 will be a year for patient-controlled health, as consumers continue to maximize agency over their own health futures. Read GoodCell CMO Salvatore G Viscomi MD’s full piece for Healthcare Global.
The COVID19 pandemic has demonstrated how rapidly research can respond to and develop therapies, setting the stage for continued scientific acceleration in the years ahead. Our Co-Founder and CSO, Brad Hamilton shares his thoughts on how this will influence cell and gene therapies with Bio-IT World for its 2021 outlook feature.